GBP/USD eyeing a test of last week’s lows just above 1.3700
GBP/USD has fallen back to fresh lows of the day in recent trade in the 1.3720s, weighed amid a broad pick up in the fortunes of the US dollar versus all of its G10 counterparts. The pair now trades lower by around 0.7% or about 90 pips. As cable has slipped to fresh lows of the day and looks to test last week’s lows around the 1.3700 level, the Dollar Index (DXY) has advanced back towards the 92.50 mark and is now back above its 200DMA.
|Today last price||1.3735|
|Today Daily Change||-0.0089|
|Today Daily Change %||-0.64|
|Today daily open||1.3824|
|Previous Daily High||1.3919|
|Previous Daily Low||1.3802|
|Previous Weekly High||1.3853|
|Previous Weekly Low||1.3706|
|Previous Monthly High||1.4017|
|Previous Monthly Low||1.3671|
|Daily Fibonacci 38.2%||1.3847|
|Daily Fibonacci 61.8%||1.3874|
|Daily Pivot Point S1||1.3778|
|Daily Pivot Point S2||1.3732|
|Daily Pivot Point S3||1.3661|
|Daily Pivot Point R1||1.3895|
|Daily Pivot Point R2||1.3965|
|Daily Pivot Point R3||1.4011|
GBP/USD Forecast: Further slides on the table
The GBP/USD plunged to 1.3728, as several factors combined to put pressure on the pound. The March UK Markit Service PMI came in at 56.3, below the 56.8 expected, although still within expansion levels. The European Medicines Agency finalized its review of the AstraZeneca vaccine and concluded that blood clots are a “very rare side effect” of the shot. The UK said that the risk of blood clots is higher for under-30s, and the local authority recommended providing a different vaccine for that age group. Meanwhile, the UK has started using the Moderna vaccine after buying 17 million doses of the jab.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.